Member Info for Matador78

Will always be better but less impressive and exciting as a large gap up.

It always falls back anyway to trade the gap which is boring as hell to be in. im happy if we finish today at 14p

it's a good price

Good Question Chilston

There were a number of large orders filled this week. Large orders generate their own gravity for obvious reasons and so people will flock in. Much like the thrashing of tails from fish in a feeding frenzy.

Remember when you first started buying stock and cast your eye wherever there was movement?

Same thing here

We'll see tomorrow. If the sentiment sticks without news from the bod then I think we're in for a change of heart and a much needed reversal.

I hope everyone takes what they need from it but I also hope very much that people leave some seed to sow.

It will be a great investment if people left it to mature.

Friday we find out whether those that bought in today did so because they understood the fundamentals or whether they bought on a whim. The rise inevitably draws a fall. Those confident will hold, those buying blind will sell. If it's strong tomorrow sentiment is good and we may end the week near 18p RNS pending. Sell everything...Buy FFWD

.

For every knee Jerk and reactionary 10%'er selling.

There is a patient holder holding.

You just can't see them.

THE WHOLE IS GREATER THAN THE SUM OF ITS PARTS

Why are you concentrating on one facet of what builds up Juvenescence?

Insilico is brilliant but it is not everything...

Juvenescence's portfolio currently includes:

Insilico Medicine, a next-generation artificial intelligence company specialising in the application of deep learning to drug discovery and ageing research;

Juvenescence AI, a joint venture with Insilico Medicine focused on the clinical development of AI generated compounds;

NetraPharma, a joint venture using artificial intelligence to improve clinical trial design;

LyGenesis, a company with technology to use a patient's own lymph nodes as bioreactors to grow functioning ectopic organs;

AgeX Therapeutics, a company applying technology related to cell immortality and pluripotency to human ageing.

It's what they're going to do together which will make you sit up and take notice.

Exposure to

*Blockchain:
*Cannabis:
*Artificial Intelligence: (speeds up the process of Drug Trials) in everyones interest. (Patients & Financials)
*Immunotherapy: (suggest you read up on this)
*Media (Social, video and music)
*Crypto:
*Diabetes:
*E Gaming/Gambling
*American Student loan debt crisis.

At first glance that may be a lot to take in but separate it and you can see that the portfolio is well balanced and serves to hedge against itself.

Buy FFWD

https://www.chinamoneynetwork.com/2018/09/20/chinese-biotech-firm-wuxi-apptec-eyes-1b-hong-kong-ipo

In June 2018, the company led a strategic funding round in Baltimore-based Insilico Medicine, an artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research.

In the same month, the company announced to invest US$60 million in setting up a biologic clinical and commercial manufacturing facility in Massachusetts, US, which is the company’s 11th global drug substance manufacturing facility.

ADVFN board on the 17th

I don't generally "tell" people to buy. I do however put up a good argument for it though.

Buy FFWD on Monday.

Equator
Wells Fargo
Bank of America

https://twitter.com/YooyaChina/status/1041877518599323649

Guess who just woke up?

If you're out..You're not in.

Buy

Well, have you ever come across a guy called Ari Emanuel in your research yet?

March 2018: NeuLion entered into an agreement to be acquired by sports and entertainment leader Endeavor in an all-cash deal valued at approximately USD $250 million. Upon completion of the transaction, NeuLion will become a privately held subsidiary of Endeavor.

May 2018: NeuLion announced the closing of its acquisition by sports and entertainment leader Endeavor.

NeuLion Digital Platform: The NeuLion Digital Platform is an end-to-end video streaming platform providing licensed components from content ingestion, encoding and management to content security, monetization and monitoring, as well as app development across all major connected devices.

The platform facilitates the streaming and distribution of premium sports and entertainment content.

NeuLion Digital Platform customers include:
The NBA,
NFL,
Univision,
UFC,
Big Ten Network,
English Football League
Sky Sports[ and others.

So I'll say it again now.

When the drums stop beating...

Look at my message from the 4th September.

Watch for news.

: )

http://fstfwd.co/uploads/documents/article/20180912-agm-notice-and-agenda-drftffil-final.pdf

It wasn't just John who aired his views.

The long termers here represent an awful lot of FFWD shares.